# EDGAR Filing Document

**Accession Number:** 0001729678
**File Stem:** 0001729678-23-000004
**Filing Date:** 2023-1
**Character Count:** 11560
**Document Hash:** 252fa5e7356db2de2b443bf5a75d1308
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001729678-23-000004.hdr.sgml**: 20230131

**ACCESSION NUMBER**: 0001729678-23-000004

**CONFORMED SUBMISSION TYPE**: SC TO-I/A

**PUBLIC DOCUMENT COUNT**: 3

**FILED AS OF DATE**: 20230131

**DATE AS OF CHANGE**: 20230131

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** BNY Mellon Alcentra Global Multi-Strategy Credit Fund, Inc.
- **CENTRAL INDEX KEY:** 0001729678
- **IRS NUMBER:** 831155988
- **FISCAL YEAR END:** 0331

**FILING VALUES:**
- **FORM TYPE:** SC TO-I/A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-91656
- **FILM NUMBER:** 23571533

**BUSINESS ADDRESS:**
- **STREET 1:** C/O BNY MELLON INVESTMENT ADVISER, INC.
- **STREET 2:** 240 GREENWICH STREET
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10286
- **BUSINESS PHONE:** 212-922-6400

**MAIL ADDRESS:**
- **STREET 1:** C/O BNY MELLON INVESTMENT ADVISER, INC.
- **STREET 2:** 240 GREENWICH STREET
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10286

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Dreyfus Alcentra Global Multi-Strategy Credit Fund, Inc.
- **DATE OF NAME CHANGE:** 20180626

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Dreyfus Alcentra Multi-Strategy Global Credit Fund, Inc.
- **DATE OF NAME CHANGE:** 20180130
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** BNY Mellon Alcentra Global Multi-Strategy Credit Fund, Inc.
- **CENTRAL INDEX KEY:** 0001729678
- **IRS NUMBER:** 831155988
- **FISCAL YEAR END:** 0331

**FILING VALUES:**
- **FORM TYPE:** SC TO-I/A

**BUSINESS ADDRESS:**
- **STREET 1:** C/O BNY MELLON INVESTMENT ADVISER, INC.
- **STREET 2:** 240 GREENWICH STREET
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10286
- **BUSINESS PHONE:** 212-922-6400

**MAIL ADDRESS:**
- **STREET 1:** C/O BNY MELLON INVESTMENT ADVISER, INC.
- **STREET 2:** 240 GREENWICH STREET
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10286

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Dreyfus Alcentra Global Multi-Strategy Credit Fund, Inc.
- **DATE OF NAME CHANGE:** 20180626

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Dreyfus Alcentra Multi-Strategy Global Credit Fund, Inc.
- **DATE OF NAME CHANGE:** 20180130

**As filed with the Securities and Exchange Commission on January 31, 2023**

**SECURITIES AND EXCHANGE COMMISSION**

**WASHINGTON, D.C. 20549**

_______________________

**SCHEDULE TO**

_______________________

**TENDER OFFER STATEMENT (Under Section 14(d)(1) or 13(e)(1)<br> of the Securities Exchange Act of 1934)**

**(Amendment No. 1)**

_______________________

**BNY Mellon Alcentra Global Multi-Strategy Credit Fund, Inc.**

**(Name of Issuer)**

**BNY Mellon Alcentra Global Multi-Strategy Credit Fund, Inc.**

**(Names of Filing Person(s) (Issuer))**

**Shares of Common Stock, Par Value $0.001 per share<br> (Title of Class of Securities)**

**26189T 104<br> (CUSIP Number of Class of Securities)**

**James Bitetto<br> BNY Mellon Investment Adviser, Inc.<br> 240 Greenwich Street<br> New York, New York 10286<br> (212) 922-6400**

**(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications on Behalf of Filing Person(s))**

_______________________

---

| |
|:---|
| &nbsp;&nbsp; ***Copy to:***<br>|
| &nbsp;&nbsp;**David Stephens, Esq. <br> Proskauer Rose LLP<br> Eleven Times Square<br> New York, New York 10036** |

---

_______________________

**January 18, 2023**<br> **(Date Tender Offer First Published, Sent or Given to Security Holders)**

_____________________________________________________________________________________________________________________

[_] Check the box if the filing relates solely to preliminary communications made before the commencement of a tender offer.

Check the appropriate boxes below to designate any transactions to which the statement relates:

[_] third party tender offer subject to Rule 14d-1

[X] issuer tender offer subject to Rule 13e-4

[_] going-private transaction subject to Rule 13e-3

[_] amendment to Schedule 13D under Rule 13d-2

Check the following box if the filing is a final amendment reporting the results of the tender offer: [_]

------

**Introductory Statement**

This Supplement relates to the Issuer Tender Offer Statement on Schedule TO (the "Statement") originally filed on January 18, 2023 by BNY Mellon Alcentra Global Multi-Strategy Credit Fund, Inc., a Maryland corporation (the "Fund"), pursuant to Rule 13e-4 under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), in connection with an offer by the Fund (the "Offer") to repurchase 2.5% of its issued and outstanding shares of common stock as of December 31, 2022, par value $0.001 per share (the "Shares"), in exchange for cash at a price equal to the Fund's most recent quarter-end net asset value ("NAV") per Share—*i.e.*, the NAV per Share determined as of December 31, 2022—upon the terms and subject to the conditions set forth in the Offer to Purchase, dated January 18, 2023 (the "Offer to Purchase"), and in the related Letter of Transmittal.

This Supplement dated January 31, 2023 to the Offer to Purchase is being filed to report a change in the portfolio management team.

**Items 1 through 9 and 11**

Except as amended herein, the information set forth in the Offer to Purchase and the related Letter of Transmittal is incorporated herein by reference in answer to Items 1 through 9 and 11 of Schedule TO.

**Item 10**

Not Applicable.

**Item 12**

(a)(1)(i) Offer to Purchase, dated January 18, 2023.<sup>1</sup>

(a)(1)(ii) Form of Letter of Transmittal.<sup>1</sup>

(a)(2) None.

(a)(3) Not Applicable.

(a)(4) Not Applicable.

(a)(5)(i) Press release issued on January 11, 2023.<sup>2</sup>

(a)(5)(ii) Supplement dated January 31, 2023 to Offer to Purchase.<sup>\*</sup>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Filing Fee Exhibit.<sup>\*</sup>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Not Applicable.

(d)(1) Management Agreement.<sup>3</sup>

(d)(2) Interim Sub-Investment Advisory Agreement.<sup>1</sup>

(d)(3) Custody Agreement.<sup>4</sup>

(d)(4) First Amendment to Custody Agreement.<sup>4</sup>

(d)(5) Second Amendment to Custody Agreement.<sup>4</sup>

(d)(6) Letter Agreement adding the Fund to Custody Agreement.<sup>4</sup>

(d)(7) Service Agreement for Transfer Agent Services.<sup>4</sup>

(d)(8) First Amendment to Service Agreement for Transfer Agent Services.<sup>4</sup>

(d)(9) Letter Agreement adding the Fund to Service Agreement for Transfer Agent Services.<sup>4</sup>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) None.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) None.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g) None.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h) None.

______________________________________

<sup>\*</sup> Filed herewith.

<sup>1</sup> Incorporated by reference to the Fund's Schedule TO-I, as filed with the Securities and Exchange Commission ("SEC") on January 18, 2023.

<sup>2</sup> Incorporated by reference to the Fund's Schedule TO-C, as filed with the SEC on January 11, 2023.

<sup>3</sup> Incorporated by reference to the corresponding Exhibits to Pre-Effective Amendment No. 4 to the Fund's Registration Statement on Form N-2 (File No. 333-223418; 811-23330) (the "Registration Statement") filed with the SEC on August 27, 2019.

<sup>4</sup> Incorporated by reference to the corresponding Exhibits to Pre-Effective Amendment No. 3 to the Registration Statement filed with the SEC on June 13, 2019.

**Item 13**

Not Applicable.

SIGNATURE

After due inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

BNY Mellon Alcentra Global Multi-Strategy Credit Fund, Inc.

---

| | |
|:---|:---|
| By: | <u>/s/ James Bitetto</u> <br> Name: James Bitetto<br> Title: Secretary<br>Dated: January 31, 2023 |

---

**<u>Exhibit Index</u>**

(a)(5)(ii) Supplement dated January 31, 2023 to Offer to Purchase.

(b) Filing Fee Exhibit.

## Ex-99

**<u>BNY MELLON ALCENTRA GLOBAL MULTI-STRATEGY CREDIT FUND, INC.</u>**

**SUPPLEMENT DATED JANUARY 31, 2023 TO JOINT PROXY STATEMENT DATED AUGUST 26, 2022 ("Proxy Statement")**

**\*\*\*\***

**SUPPLEMENT DATED JANUARY 31, 2023 TO OFFER TO PURCHASE** 

**Up to 2.5% of the Issued and Outstanding Shares of Common Stock**

**of** 

**BNY Mellon Alcentra Global Multi-Strategy Credit Fund, Inc.**

**at** 

**Net Asset Value Per Share**

**by** 

**BNY Mellon Alcentra Global Multi-Strategy Credit Fund, Inc.**

**in Exchange for Cash** 

**("January 18, 2023 Offer to Purchase")**

**The following information supersedes and replaces any contrary information in the "Information about the Funds' Primary Portfolio Managers" section of the Proxy Statement and supplements any information provided in the "Additional Information" section of the January 18, 2023 Offer to Purchase:** 

On January 31, 2023, the Fund announced that the Fund's portfolio management team consisted of Chris Barris, Brandon Chao and Kevin Cronk. Mr. Jonathan DeSimone no longer serves as a primary portfolio manager of the Fund. BNYM Investment Adviser will continue to serve as the Fund's investment adviser, and Alcentra NY, LLC will continue to serve as the Fund's sub-adviser. The investment strategies of the Fund are not changing as a result of the change.

In addition, a "key person event" (as that term is defined in the Fund's initial public offering prospectus, as supplemented, and further revised) will be triggered if any one of Chris Barris, Brandon Chao or Kevin Cronk depart Alcentra or cease to manage/supervise the affairs of the Fund during the life of the Fund.

## Ex-Filing

**Calculation of Filing Fees Table**

**SC TO-I/A**

(Form Type)

**BNY Mellon Alcentra Global Multi-Strategy Credit Fund, Inc.**

(Exact Name of Registrant as Specified in its Charter)

**Table 1 – Transaction Value**

---

| | | | |
|:---|:---|:---|:---|
|  | &nbsp;&nbsp;**<u>Transaction Valuation</u>** | &nbsp;&nbsp;**<u>Fee Rate</u>** | &nbsp;&nbsp;**<u>Amount of Filing Fee</u>** |
| &nbsp;&nbsp;**Fees to Be Paid** | &nbsp;&nbsp;**$0** | &nbsp;&nbsp;**-** | &nbsp;&nbsp;**$0** |
| &nbsp;&nbsp;**Fees Previously Paid** | &nbsp;&nbsp;**$4285531.50<sup>(a)</sup>** | &nbsp;&nbsp;**0.00011020%** | &nbsp;&nbsp;**$472.27<sup>(b)</sup>** |
| &nbsp;&nbsp;**Total Transaction Valuation** | &nbsp;&nbsp;**$4285531.50<sup>(a)</sup>** |  |  |
| &nbsp;&nbsp;**Total Fees Due for Filing** |  |  |  |
| &nbsp;&nbsp;**Total Fees Previously Paid** |  |  | &nbsp;&nbsp;**$472.27<sup>(c)</sup>** |
| &nbsp;&nbsp;**Total Fee Offsets** |  |  | &nbsp;&nbsp;**$0** |
| &nbsp;&nbsp;**Net Fee Due** |  |  | &nbsp;&nbsp;**$0** |

---

_______________________

(a) Estimated for purposes of calculating the amount of the filing fee only. The amount is based upon the offer to purchase up to 52,810 shares of common stock (2.5% of the shares of common stock outstanding as of December 31, 2022, rounded to the nearest whole share) based upon a price of $81.15 (the net asset value per share as of September 30, 2022).

(b) Calculated at 0.00011020% of the Transaction Valuation.

(c) The fee of $472.27 was paid by the Fund in connection with the filing of its Schedule TO-I on January 18, 2023. This is a supplement to the Schedule TO and is being filed to report a change in the portfolio management team.